Neko Health, a leading preventative healthcare technology company co-founded by Hjalmar Nilsonne and Daniel Ek (founder of Spotify), has raised $260 million in a Series B funding round led by Lightspeed Venture Partners, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. This brings Neko Health’s total funding to over $325 million. The company is revolutionizing healthcare with its AI-powered body scan, which maps millions of health data points in just minutes. The scan, priced at £299, helps detect a wide range of health risks, including skin cancer, metabolic syndrome, pre-diabetes, cardiovascular disease, and blood abnormalities.

Neko Health’s approach aligns with the growing global consensus that preventative care is essential for addressing the global health crisis. Its technology has been recognized by medical experts as a valuable tool for early detection and disease prevention. Since launching in February 2023, Neko Health has completed 10,000 scans across its locations in Stockholm and London, with a remarkable 80% retention rate, as most patients book their next scan before leaving. Demand for the Neko Body Scan remains high, with a global waiting list exceeding 100,000 people.

The recent funding will support Neko Health’s expansion, allowing the company to open new locations, enhance its AI-powered platform, and grow its workforce to meet the increasing demand for its services. This investment will help Neko Health continue its mission to provide accessible, preventative healthcare and transform how people manage their health.